Related Experiment Video
Updated: Aug 17, 2025

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
Mining Potential Drug Targets for Osteoporosis Based on CeRNA Network.
Zheng Wang1,2, Xiao-Fei Zhang3, Mao-Peng Wang1,2
1Department of Joint Surgery, Tianjin Hospital, Tianjin, China.
This study identifies key osteoporosis (OP) genes, microRNAs (miRNAs), and circular RNAs (circRNAs) to build a ceRNA network. Benzo[a]pyrene shows potential as a therapeutic drug for OP treatment.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- Osteoporosis (OP) is a significant skeletal disorder.
- Identifying molecular players in OP pathogenesis is crucial for effective therapy.
Purpose of the Study:
- To identify key pathological hub genes, microRNAs (miRNAs), and circular RNAs (circRNAs) in osteoporosis.
- To construct a competing endogenous RNA (ceRNA) network for OP.
- To explore potential biomarkers and drug targets for osteoporosis therapy.
Main Methods:
- Downloaded and analyzed Gene Expression Omnibus (GEO) microarray datasets (GSE7158, GSE201543, GSE161361).
- Identified differentially expressed genes (DEGs) and screened hub genes using machine learning algorithms.
- Predicted target miRNAs and circRNAs, constructed the ceRNA network using Cytoscape, and performed functional enrichment analysis.
- Verified hub genes via receiver operating characteristic (ROC) curve and RT-qPCR; predicted and analyzed potential drug molecules using DSigDB and molecular docking.
Main Results:
- Identified 179 DEGs, with BAG2, MME, SLC14A1, and TRIM44 identified as hub genes.
- Established an mRNA-miRNA-circRNA ceRNA network involving 3 target miRNAs and 362 target circRNAs.
- Hub genes demonstrated good diagnostic performance and significant differential expression in an OP animal model.
- Benzo[a]pyrene was predicted as a potential drug molecule that binds to relevant protein receptors.
Conclusions:
- An mRNA-miRNA-circRNA network offers novel insights into osteoporosis pathogenesis.
- Benzo[a]pyrene presents potential as a therapeutic agent for osteoporosis, guiding clinical treatment.
More Related Videos
07:00Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
Published on: September 26, 2016
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
Related Concept Videos
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Osteoclasts in Bone Remodeling
The Nucleolus
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...